Danaher Overview
- Year Founded
-
1969

- Status
-
Public
- Employees
-
63,000

- Stock Symbol
-
DHR

- Investments
-
87
- Share Price
-
$195.91
- (As of Monday Closing)
Danaher General Information
Description
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Then, through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in the life science and diagnostic industries after the late 2023 divestiture of its environmental and applied solutions group, Veralto.
Contact Information
Website
www.danaher.comCorporate Office
- 2200 Pennsylvania Avenue, North West
- Suite 800 West
- Washington, DC 20037
- United States
Corporate Office
- 2200 Pennsylvania Avenue, North West
- Suite 800 West
- Washington, DC 20037
- United States
Danaher Stock Performance
As of 28-Apr-2025, Danaher’s stock price is $195.91. Its current market cap is $140B with 716M shares.
(As of Monday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$195.91 | $197.14 | $171.00 - $281.70 | $140B | 716M | 4.92M | $5.19 |
Danaher Financials Summary
As of 31-Mar-2025, Danaher has a trailing 12-month revenue of $23.8B.
In Thousands, USD |
TTM 31-Mar-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 |
---|---|---|---|---|
EV | 161,742,308 | 180,701,259 | 180,734,397 | 208,988,860 |
Revenue | 23,820,000 | 23,875,000 | 23,890,000 | 26,643,000 |
EBITDA | 7,083,000 | 7,159,000 | 7,193,000 | 9,441,000 |
Net Income | 3,765,000 | 3,899,000 | 4,764,000 | 7,209,000 |
Total Assets | 79,116,000 | 77,542,000 | 84,488,000 | 84,350,000 |
Total Debt | 16,477,000 | 17,146,000 | 19,536,000 | 20,616,000 |
Danaher Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Danaher Comparisons
Industry
Financing
Details
Danaher Competitors (4)
One of Danaher’s 4 competitors is Fortive, a Corporation company based in Everett, WA.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Fortive | Corporation | Everett, WA | ||||
3M | Corporation | Saint Paul, MN | ||||
ZEISS International | Formerly PE-Backed | Oberkochen, Germany | ||||
Bio-Rad Laboratories | Corporation | Hercules, CA |
Danaher Patents
Danaher Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
FR-3150059-A1 | Intelligent electric motor with electrical redundancy and integrated fault detection | Pending | 13-Jun-2023 | ||
FR-2959266-A1 | Closure device for linearly displacing obturator in front of opening of case, has rotary actuator assuring linear displacement between opening and closing positions by controlling rotation of tracks | Active | 27-Apr-2010 | ||
FR-2959266-B1 | Quick open filling device | Active | 27-Apr-2010 | ||
US-20110088384-A1 | Apparatus and methods for controlling hydraulically-powered apparatus | Active | 21-Oct-2009 | ||
FR-2934438-B1 | Integrated electric actuator | Active | 22-Jul-2008 | F16H25/2252 |
Danaher Signals
Danaher Investments & Acquisitions (87)
Danaher’s most recent deal was a Later Stage VC with Indica Labs. The deal was made on 08-Jan-2025.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
Indica Labs | 08-Jan-2025 | Later Stage VC | Enterprise Systems (Healthcare) | ||
Abdulla Fouad (AFMS Business Assets in Saudi Arabia) | 30-Sep-2024 | Corporate Asset Purchase | Buildings and Property | ||
Genedata | 19-Aug-2024 | Merger/Acquisition | Other Healthcare Technology Systems | ||
Abcam | 06-Dec-2023 | Merger/Acquisition | Discovery Tools (Healthcare) | ||
Summus | 17-Aug-2023 | Later Stage VC | Clinics/Outpatient Services |
Danaher ESG
Risk Overview
Risk Rating
Updated November, 20, 2024
8.52 | Negl Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 15,109
Rank
Percentile

Pharmaceuticals
Industry
of 861
Rank
Percentile

Laboratory Equipment and Services
Subindustry
of 60
Rank
Percentile

Danaher Exits (18)
Danaher’s most recent exit was on 26-Jun-2020 from Single Use Support. The exit was categorized as .
Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
---|---|---|---|---|---|
Single Use Support | 26-Jun-2020 | Completed |
|
||
VIA (Automotive) | 11-Jun-2014 | Completed |
|
||
Teletrac | 02-Aug-2013 | Completed |
|
||
Navman Wireless | 29-Jan-2013 | Completed |
|
||
Esko | 22-Mar-2011 | Merger/Acquisition | Completed |
Danaher Affiliates
Subsidiaries (40)
Name | Industry | Location | Year Founded |
---|---|---|---|
Danaher Ventures | Washington, DC | 2017 | |
Precision Nanosystems | Vancouver, Canada | 2010 | |
Aquatic Informatics | Vancouver, Canada | 2003 | |
Fluke Networks | Everett, WA | 2000 | |
Abcam | Cambridge, United Kingdom | 1998 |
Danaher FAQs
-
When was Danaher founded?
Danaher was founded in 1969.
-
Where is Danaher headquartered?
Danaher is headquartered in Washington, DC.
-
What is the size of Danaher?
Danaher has 63,000 total employees.
-
What industry is Danaher in?
Danaher’s primary industry is Diagnostic Equipment.
-
Is Danaher a private or public company?
Danaher is a Public company.
-
What is Danaher’s stock symbol?
The ticker symbol for Danaher is DHR.
-
What is the current stock price of Danaher?
As of 28-Apr-2025 the stock price of Danaher is $195.91.
-
What is the current market cap of Danaher?
The current market capitalization of Danaher is $140B.
-
What is Danaher’s current revenue?
The trailing twelve month revenue for Danaher is $23.8B.
-
Who are Danaher’s competitors?
Fortive, 3M, ZEISS International, and Bio-Rad Laboratories are competitors of Danaher.
-
What is Danaher’s annual earnings per share (EPS)?
Danaher’s EPS for 12 months was $5.19.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »